Istraživači
Lazarević, Slavica
Results 21-40 of 60
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2023 | Exploring Simvastatin Bioaccumulation and Biotransformation in Probiotic Bacteria for Enhanced Insight into Drug-Microbiota Interactions![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2023 | Antihypertensive drugs in blood donations in Serbia - observational study![]() | Budakov Obradović, Zorana | Article | 22M22 |
| 2023 | Evaluation of the influence of bile acids on clindamycin hydrochloride permeability using in vitro PAMPA skin model![]() | Zaklan, Dragana | Conference Paper | Mp. category will be shown later |
| 2023 | Lekovi u prometu 2023 : priručnik o lekovima i njihovoj primeni![]() | Stanulović, Milan
Goločorbin-Kon, Svetlana
| Other | Mp. category will be shown later |
| 2023 | Influence of probiotics and bile acids on the gliclazide permeation: in vitro PAMPA model study![]() | Pavlović, Nebojša | Conference Paper | Mp. category will be shown later |
| 2023 | Zaštita intelektualne svojine lekova- uticaj na potrošnju antidijabetika u Srbiji![]() | Prodanović, Dušan | Conference Paper | Mp. category will be shown later |
| 2023 | Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions![]() | Đanić, Maja | Article | 21aM21a |
| 2023 | Bile acids alter clindamycin permeation through the skin: in vitro permeability study![]() | Zaklan, Dragana | Conference Paper | Mp. category will be shown later |
| 2023 | Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II![]() | Mikov, Momir M | Article | 21aM21a |
| 2022 | In-home drug inventory among students – storage, use and disposal of drugs![]() | Tomas, Petrović Ana | Conference Paper | Mp. category will be shown later |
| 2022 | Gut microbiota metabolism and bioaccumulation of drugs![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2022 | Biomarker-based thiopurine therapy for inflammatory bowel disease![]() | Lazarević, Slavica | Conference Paper | Mp. category will be shown later |
| 2022 | Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease![]() | Lazarevic, Slavica | Article | 21aM21a |
| 2022 | Personalized thiopurine therapy of inflammatory bowel disease - the role of gut microbiota![]() | Lazarević, Slavica | Conference Paper | Mp. category will be shown later |
| 2022 | Plasma Distribution of Methotrexate and Its Polyglutamates in Pediatric Acute Lymphoblastic Leukemia: Preliminary Insights![]() | Rajšić, Ivana; Lazarević, Slavica | Article | 22M22 |
| 2022 | Targeting gut microbiota for the individualization of thiopurine therapy of inflammatory bowel disease![]() | Lazarević, Slavica | Conference Paper | Mp. category will be shown later |
| 2021 | In Silico Analysis of Keto Derivatives of Bile Acids as Cardioprotective TGR5 Activators![]() | Pavlović, Nebojša | Conference Paper | Mp. category will be shown later |
| 2021 | Gut Microbiota Generated Metabolites of Simvastatin![]() | Đanić,Maja | Conference Paper | Mp. category will be shown later |
| 2021 | Cardioprotective Potential of Semisynthetic Bile Acids – Rational Drug Design![]() | Lazarević, Slavica | Conference Paper | Mp. category will be shown later |
| 2021 | PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bile acids![]() | Đanić, Maja | Article | 21aM21a |
